FDCDDQ
ATOS icon

Federation des caisses Desjardins du Quebec’s Atossa Therapeutics ATOS Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-707
Closed -$7.13K – 2738
2025
Q1 		$7.13K Hold
707
– – ﹤0.01% 2070
2024
Q4 		$10K Hold
707
– – ﹤0.01% 1883
2024
Q3 		$16.1K Hold
707
– – ﹤0.01% 1728
2024
Q2 		$12.6K Hold
707
– – ﹤0.01% 1746
2024
Q1 		$19.1K Hold
707
– – ﹤0.01% 1651
2023
Q4 		$9.33K Sell
707
-133
-16% -$1.44K ﹤0.01% 1768
2023
Q3 		$9.29K Hold
840
– – ﹤0.01% 1781
2023
Q2 		$15.9K Hold
840
– – ﹤0.01% 1637
2023
Q1 		$9.13K Hold
840
– – ﹤0.01% 1786
2022
Q4 		$6.67K Hold
840
– – ﹤0.01% 1973
2022
Q3 		$10.5K Hold
840
– – ﹤0.01% 1903
2022
Q2 		$13.7K Hold
840
– – ﹤0.01% 1872
2022
Q1 		$15.8K Hold
840
– – ﹤0.01% 1895
2021
Q4 		$20.2K Hold
840
– – ﹤0.01% 1821
2021
Q3 		$41.1K Sell
840
-368
-30% -$21.4K ﹤0.01% 1662
2021
Q2 		$115K Buy
1,208
+35
+3% +$1.85K ﹤0.01% 1374
2021
Q1 		$37.1K Hold
1,173
– – ﹤0.01% 1635
2020
Q4 		$16.7K Hold
1,173
– – ﹤0.01% 1788
2020
Q3 		$42.6K Buy
1,173
+266
+29% +$12.8K ﹤0.01% 1286
2020
Q2 		$51.7K Sell
907
-26
-3% -$922 ﹤0.01% 1203
2020
Q1 		$18.6K Buy
933
+66
+8% +$1.3K ﹤0.01% 1505
2019
Q4 		$20.4K Hold
867
– – ﹤0.01% 1721
2019
Q3 		$25.5K Hold
867
– – ﹤0.01% 1620
2019
Q2 		$33.1K Sell
867
-333
-28% -$13.3K ﹤0.01% 1588
2019
Q1 		$63.4K Buy
+1,200
New +$35K ﹤0.01% 1263

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ATOS Position: Q2 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Atossa Therapeutics (ATOS) in Q2 2025, closing a stake of 707 shares — an estimated $7.13K sold.

Federation des caisses Desjardins du Quebec first reported a position in ATOS in Q1 2019 and held it in 25 quarters. The position peaked at $115K in Q2 2021. 84 funds tracked by Wall St. Rank hold ATOS as of Q2 2025.

  • Federation des caisses Desjardins du Quebec reported no remaining Atossa Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 707 Atossa Therapeutics shares in Q2 2025, an estimated $7.13K.
  • Federation des caisses Desjardins du Quebec first reported a position in Atossa Therapeutics in Q1 2019 and held it in 25 quarters.
  • Federation des caisses Desjardins du Quebec's Atossa Therapeutics position peaked at $115K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2025, filed 14 Aug 2025.